100 related articles for article (PubMed ID: 18523030)
1. Interleukin-8 and atrial fibrillation.
Melenovsky V; Lip GY
Europace; 2008 Jul; 10(7):784-5. PubMed ID: 18523030
[No Abstract] [Full Text] [Related]
2. Source of inflammatory markers in patients with atrial fibrillation.
Liuba I; Ahlmroth H; Jonasson L; Englund A; Jönsson A; Säfström K; Walfridsson H
Europace; 2008 Jul; 10(7):848-53. PubMed ID: 18523031
[TBL] [Abstract][Full Text] [Related]
3. Inflammation: another potential mechanism between diabetes mellitus and atrial fibrillation.
Liu T; Li G
Am J Cardiol; 2008 Jun; 101(11):1681-2. PubMed ID: 18489956
[No Abstract] [Full Text] [Related]
4. Inflammation and atrial fibrillation: cause or effect?
Boos CJ; Lip GY
Heart; 2008 Feb; 94(2):133-4. PubMed ID: 18195117
[No Abstract] [Full Text] [Related]
5. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion.
Henningsen KM; Therkelsen SK; Bruunsgaard H; Krabbe KS; Pedersen BK; Svendsen JH
Scand J Clin Lab Invest; 2009; 69(3):425-32. PubMed ID: 19204850
[TBL] [Abstract][Full Text] [Related]
6. The impact of inflammation on the development, successful cardioversion, recurrence and/or perpetuation of atrial fibrillation.
Turhan H; Aksoy Y; Yetkin E; Kosar F
Int J Cardiol; 2007 May; 118(2):256-7; author reply 258-61. PubMed ID: 17034885
[No Abstract] [Full Text] [Related]
7. Can perioperative C-reactive protein and interleukin-6 levels predict atrial fibrillation after coronary artery bypass surgery?
Ziabakhsh-Tabari S
Saudi Med J; 2008 Oct; 29(10):1429-31. PubMed ID: 18946567
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-18 among atrial fibrillation patients in the absence of structural heart disease.
Luan Y; Guo Y; Li S; Yu B; Zhu S; Li S; Li N; Tian Z; Peng C; Cheng J; Li Q; Cui J; Tian Y
Europace; 2010 Dec; 12(12):1713-8. PubMed ID: 20833691
[TBL] [Abstract][Full Text] [Related]
9. Mean platelet volume is elevated during paroxysmal atrial fibrillation: a marker of increased platelet activation?
Colkesen Y; Acil T; Abayli B; Yigit F; Katircibasi T; Kocum T; Demircan S; Sezgin A; Ozin B; Muderrisoglu H
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):411-4. PubMed ID: 18600091
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory biomarkers and risk of lung cancer.
Lagiou P; Trichopoulos D
J Natl Cancer Inst; 2011 Jul; 103(14):1073-5. PubMed ID: 21685358
[No Abstract] [Full Text] [Related]
11. Atrial fibrillation, the prothrombotic state, inflammation, and gender.
Conway DS; Lip GY
Am J Cardiol; 2005 Mar; 95(6):819. PubMed ID: 15757625
[No Abstract] [Full Text] [Related]
12. Atrial fibrillation and inflammation: quest for the missing link in the etiopathogenesis of AF.
Dixit S
Heart Rhythm; 2010; 7(2):155-6. PubMed ID: 20022817
[No Abstract] [Full Text] [Related]
13. Cardioversion for atrial fibrillation: does inflammation matter?
Watson T; Kakar P; Lip GY
Am J Cardiol; 2007 Jun; 99(11):1617-8. PubMed ID: 17531593
[No Abstract] [Full Text] [Related]
14. [C-reactive protein and atrial fibrillation. An old marker looking for a new target].
Hernández Madrid A
Rev Esp Cardiol; 2006 Feb; 59(2):94-8. PubMed ID: 16540029
[No Abstract] [Full Text] [Related]
15. Do your heart a favor: eat fish.
Health News; 2005 Oct; 11(10):9. PubMed ID: 16252355
[No Abstract] [Full Text] [Related]
16. The role of inflammation in atrial fibrillation.
Boos CJ; Lip GY
Int J Clin Pract; 2005 Aug; 59(8):870-2. PubMed ID: 16033603
[No Abstract] [Full Text] [Related]
17. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: a prospective study.
Kunisaki KM; Rice KL; Janoff EN; Rector TS; Niewoehner DE
Ther Adv Respir Dis; 2008 Apr; 2(2):55-64. PubMed ID: 19124359
[TBL] [Abstract][Full Text] [Related]
18. New hope for the prevention of recurrent atrial fibrillation.
Abdelhadi RH; Chung MK; Van Wagoner DR
Eur Heart J; 2004 Jul; 25(13):1089-90. PubMed ID: 15231364
[No Abstract] [Full Text] [Related]
19. Usefulness of C-reactive protein in predicting early and late recurrences after atrial fibrillation ablation.
Lellouche N; Sacher F; Wright M; Nault I; Brottier J; Knecht S; Matsuo S; Lomas O; Hocini M; Haïssaguerre M; Jaïs P
Europace; 2009 May; 11(5):662-4. PubMed ID: 19351632
[TBL] [Abstract][Full Text] [Related]
20. Psoriasis, inflammation, and atrial fibrillation.
Liu T; Li G
Am J Cardiol; 2008 Sep; 102(5):647. PubMed ID: 18721531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
